Envestnet Asset Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,763
| Closed | -$334K | – | 4714 |
|
|
2025
Q4 | $334K | Buy |
+1,763
| New | +$326K | ﹤0.01% | 3959 |
|
|
2025
Q1 | – | Sell |
-1,408
| Closed | -$221K | – | 4358 |
|
|
2024
Q4 | $221K | Sell |
1,408
-1,837
| -57% | -$309K | ﹤0.01% | 4048 |
|
|
2024
Q3 | $576K | Buy |
3,245
+488
| +18% | +$86.6K | ﹤0.01% | 3466 |
|
|
2024
Q2 | $464K | Sell |
2,757
-19,179
| -87% | -$3.14M | ﹤0.01% | 3504 |
|
|
2024
Q1 | $3.65M | Buy |
21,936
+1,765
| +9% | +$292K | ﹤0.01% | 2197 |
|
|
2023
Q4 | $3.33M | Sell |
20,171
-1,778
| -8% | -$274K | ﹤0.01% | 2157 |
|
|
2023
Q3 | $3.42M | Buy |
21,949
+609
| +3% | +$97.3K | ﹤0.01% | 2056 |
|
|
2023
Q2 | $3.33M | Buy |
21,340
+1,166
| +6% | +$186K | ﹤0.01% | 1952 |
|
|
2023
Q1 | $3.27M | Buy |
20,174
+6,705
| +50% | +$1.08M | ﹤0.01% | 1889 |
|
|
2022
Q4 | $2.15M | Buy |
13,469
+867
| +7% | +$137K | ﹤0.01% | 2111 |
|
|
2022
Q3 | $1.77M | Sell |
12,602
-32
| -0.3% | -$4.84K | ﹤0.01% | 2155 |
|
|
2022
Q2 | $1.84M | Sell |
12,634
-2,462
| -16% | -$367K | ﹤0.01% | 2155 |
|
|
2022
Q1 | $2.45M | Buy |
15,096
+1,614
| +12% | +$261K | ﹤0.01% | 2083 |
|
|
2021
Q4 | $2.55M | Buy |
13,482
+3,418
| +34% | +$659K | ﹤0.01% | 2010 |
|
|
2021
Q3 | $2.03M | Buy |
10,064
+683
| +7% | +$143K | ﹤0.01% | 2079 |
|
|
2021
Q2 | $1.89M | Buy |
9,381
+1,300
| +16% | +$242K | ﹤0.01% | 2096 |
|
|
2021
Q1 | $1.42M | Buy |
8,081
+541
| +7% | +$97.8K | ﹤0.01% | 2172 |
|
|
2020
Q4 | $1.28M | Buy |
7,540
+1,189
| +19% | +$196K | ﹤0.01% | 2050 |
|
|
2020
Q3 | $1.03M | Sell |
6,351
-12,630
| -67% | -$2.05M | ﹤0.01% | 1992 |
|
|
2020
Q2 | $3.09M | Buy |
18,981
+4,331
| +30% | +$658K | ﹤0.01% | 1358 |
|
|
2020
Q1 | $1.88M | Buy |
+14,650
| New | +$1.97M | ﹤0.01% | 1453 |
|
|
2017
Q1 | – | Sell |
-144
| Closed | -$16K | – | 3110 |
|
|
2016
Q4 | $16K | Buy |
+144
| New | +$15.7K | ﹤0.01% | 2695 |
|
|
2015
Q4 | – | Sell |
-1,012
| Closed | -$116K | – | 2981 |
|
|
2015
Q3 | $116K | Sell |
1,012
-56,213
| -98% | -$7.44M | ﹤0.01% | 2276 |
|
|
2015
Q2 | $7.72M | Buy |
57,225
+15,400
| +37% | +$2.05M | 0.04% | 457 |
|
|
2015
Q1 | $5.42M | Buy |
41,825
+12,036
| +40% | +$1.51M | 0.03% | 532 |
|
|
2014
Q4 | $3.44M | Buy |
+29,789
| New | +$3.36M | 0.03% | 283 |
|
|
2014
Q2 | – | Sell |
-9,598
| Closed | -$873K | – | 2707 |
|
|
2014
Q1 | $873K | Buy |
9,598
+5,767
| +151% | +$561K | 0.01% | 507 |
|
|
2013
Q4 | $339K | Buy |
3,831
+1,609
| +72% | +$135K | ﹤0.01% | 710 |
|
|
2013
Q3 | $184K | Sell |
2,222
-577
| -21% | -$45.3K | ﹤0.01% | 814 |
|
|
2013
Q2 | $192K | Buy |
+2,799
| New | +$195K | ﹤0.01% | 809 |
|
Other funds holding BBH
MIM
CCA
BFG
Envestnet Asset Management's BBH Position: Q1 2026 in Review
Envestnet Asset Management sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 1,763 shares — an estimated $334K sold.
Envestnet Asset Management first reported a position in BBH in Q2 2013 and held it in 30 quarters. The position peaked at $7.72M in Q2 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Envestnet Asset Management reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
- Envestnet Asset Management sold 1,763 VanEck Biotech ETF shares in Q1 2026, an estimated $334K.
- Envestnet Asset Management first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 30 quarters.
- Envestnet Asset Management's VanEck Biotech ETF position peaked at $7.72M in Q2 2015.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.